A mathematical model of breast cancer treatment with CMF and doxorubicin
DOI10.1007/S11538-010-9549-9zbMATH Open1226.92042OpenAlexW2101323077WikidataQ51691306 ScholiaQ51691306MaRDI QIDQ644402FDOQ644402
Rachel Roe-Dale, David Isaacson, Michael Kupferschmid
Publication date: 4 November 2011
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s11538-010-9549-9
Recommendations
- Mathematical model of triple-negative breast cancer in response to combination chemotherapies
- A mathematical model of breast and ovarian cancer treated with Paclitaxel
- Mathematical modeling of the immune-chemotherapeutic treatment of breast cancer under some control parameters
- A mathematical model of cancer treatment by chemotherapy
- A mathematical model of breast cancer development, local treatment and recurrence
- A mathematical model of chemotherapy response to tumour growth
- Some mathematical models for cancer chemotherapy
- A mathematical model of cancer chemotherapy with an optimal selection of parameters
- Mathematical model for the estrogen paradox in breast cancer treatment
Medical applications (general) (92C50) Biochemistry, molecular biology (92C40) Dynamical systems in biology (37N25) Probabilistic models, generic numerical methods in probability and statistics (65C20) Cell biology (92C37)
Cites Work
Cited In (12)
- Mathematical model of triple-negative breast cancer in response to combination chemotherapies
- Mathematical model for the estrogen paradox in breast cancer treatment
- A mathematical model of cell cycle effects in gastric cancer chemotherapy
- Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines
- Mathematical modeling of tumor growth: the MCF-7 breast cancer cell line
- Mathematics + Cancer: An Undergraduate "Bridge" Course in Applied Mathematics
- Modeling of mouse experiments suggests that optimal anti-hormonal treatment for breast cancer is diet-dependent
- Modelling the Effects of Paclitaxel and Cisplatin on Breast and Ovarian Cancer
- Optimizing combination therapy in a murine model of HER2+ breast cancer
- USING COMPUTER SIMULATIONS FOR EVALUATING THE EFFICACY OF BREAST CANCER CHEMOTHERAPY PROTOCOLS
- Optimization of additive chemotherapy combinations for an in vitro cell cycle model with constant drug exposures
- A mathematical model of doxorubicin penetration through multicellular layers
This page was built for publication: A mathematical model of breast cancer treatment with CMF and doxorubicin
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q644402)